Abstract Usher syndrome (USH) is defined by the association of sensorineural deafness and visual impairment due to retinitis pigmentosa. The syndrome has three distinct clinical subtypes, referred to as USH1, USH2, and USH3. Each subtype is genetically heterogeneous, and 12 loci have been detected so far. Four genes have been identified, namely, USH1B, USH1C, USH1D, and USH2A. USH1B, USH1C, and USH1D encode an unconventional myosin (myosin VIIA), a PDZ domain-containing protein (harmonin), and a cadherin-like protein (cadherin-23), respectively. Mutations of these genes cause primary defects of the sensory cells in the inner ear, and probably also in the retina. In the inner ear, the USH1 genes, I propose, are involved in the same signaling pathway, which may control development and/or maintenance of the hair bundles of sensory cells via an adhesion force (a) at the junctions between these cells and supporting cells and (b) at the level of the lateral links that interconnect the stereocilia. In contrast, the molecular pathogenesis of USH2A, which is owing to a defect of a novel extracellular matrix protein, is likely to be different from that of USH1.
INTRODUCTION
Over 400 syndromes with deafness as one of the symptoms have been described in the literature (46) . They include a vast ensemble of hereditary monogenic diseases in which hearing loss is associated with miscellaneous disorders of the musculoskeletal, cardiovascular, urogenital, nervous, endocrine, digestive, or integumentary systems. About 40 of these syndromes include an ocular disorder (45) . Among them is Usher syndrome (USH), defined by a bilateral sensorineural deafness that originates in the cochlea (the auditory sensory organ) and a loss of vision due to retinitis pigmentosa. This syndrome is the most frequent cause of deafness accompanied by blindness. It accounts for more than 50% of individuals who are both deaf and blind (142) , about 18% of retinitis pigmentosa cases, and 3%-6% of congenital deafness cases (20) . Its prevalence is between 1/16,000 and 1/50,000, based on studies of Scandinavian (48, 51, 84, 104, 120) , Columbian (132) , British (57), and American populations (20); for individuals between the ages of 30 and 49, the prevalence approaches 1/10,000 (57).
(balance deficiency), and prepubertal onset retinitis pigmentosa. Vestibular dysfunction manifests clinically as a delay in motor development. Affected children cannot sit without support at 6 months of age and often do not walk before 18 months (100, 127 ). An ataxia of vestibular origin is occasionally observed. The retinopathy appears as a loss of night vision and a restriction of the visual field during childhood, and eventually, as a visual acuity loss that rapidly progresses to blindness. Anomalies of light-evoked electrical response of the retina can be detected as soon as 2 to 3 years of age by electroretinography, thus permitting early diagnosis of the disease. Later, fundus anomalies develop, which consist of pigment deposition likened to bone spicules around mid-periphery of the retina, thereafter extending inward and outward, and a narrowing of blood vessels. USH2 is mainly distinguished from USH1 by a less severe deafness, i.e., a mild hearing loss for low frequency sounds and a severe hearing loss for high frequency sounds, with the absence of the vestibular dysfunction. The loss of night vision develops around puberty (the age of onset partly overlaps that of USH1). The progression of the visual impairment seems to present a higher variability than in USH1 (145) . Patients usually have fundoscopic anomalies beyond childhood (72) . A third type, USH3, has been described as distinct from USH2 because of the progressiveness of the hearing loss and the occasional presence of vestibular dysfunction (47, 67, 68) . In each of these forms, retinitis pigmentosa can be accompanied by cataract (9) .
Initially, the respective proportions of USH1 and USH2 cases were reported to be 90% and 10% (51). This evaluation, however, was biased, as the examined patients were severely to profoundly deaf. In more recent analyses of patients from the United States and Northern Europe, USH1 and USH2 were reported between 33% and 44% and between 56% and 67%, respectively (38, 57, 108, 120) . In Colombia however, 70% of the USH cases have been diagnosed as USH1 (132) , a likely overestimated value as it is based on the screening of individuals attending schools for the deaf (whereas the degree of hearing loss of USH2 allows for a normal schooling). USH3 had first been evaluated at a very low percentage (31) . Subsequently, the existence of this form was considered uncertain (127) . The finding of USH3 in Finland, where it is the most common form of Usher syndrome (40% of cases) (107), due to a founder effect in this population, definitively established the reality of this form. Recently, USH3 was reported to account for 20% of the USH cases in the city of Birmingham (United Kingdom) (57).
Although the histopathological data on the syndrome are sparse and often related to undefined USH subtypes, examination of the temporal bone has been documented in some cases (131, 146) . Whatever the supposed USH subtype, a severe degeneration of the organ of Corti (the auditory sensory epithelium) was observed, at least in the basal turn of the cochlea. The cochlear ganglion (devoted to afferent innervation) was atrophied. In USH1, the structure of the vestibular end organs varied from normal to a severe degeneration of certain neuroepithelial areas. No vestibular anomaly was detected in USH2 and USH3. In several patients affected by an undefined USH subtype, ciliar anomalies have been reported of both the connecting cilium of photoreceptor cells (11, 18, 60) and the cilium of olfactory receptor neurons (7) . Slow sperm motility and an abnormal structure of the sperm cilium have also been described and proposed to account for patients' decreased fertility (60) . Finally, bronchiectasis and reduced nasal mucociliary clearance, which were observed in some USH1 patients, might also be related to a ciliar dysfunction (18). Recently, sperm anomalies have been sought in USH2A patients, but no anomaly of the cilium could be detected (141) ; it is thus tempting to ascribe the reported ciliar anomalies to the USH1 form.
LOCI IDENTIFICATION *
The first USH locus to be mapped was USH2A, for Usher type II, in 1990. It was assigned to the distal part of chromosome 1q through the study of affected families from the United States and Europe (74) . Next, the USH1A locus was found by analysis of a population from Poitou-Charentes, in the west of France (66) ; this locus has only been detected in this population so far. The first locus for USH3 was reported in 1995, in Finnish families (122) . At present, evidence for 12 distinct genetic loci for Usher syndrome has been obtained (see Table 1 ), namely, 6 loci for USH1, USH1A at 14q32 (MIM 276900) (66) , USH1B at 11q13.5 (MIM 276903) (73, 128) , USH1C at 11p15.1 (MIM 276904) (128) , USH1D at 10q (MIM 601067) (149) , USH1E at 21q21 (MIM 602097) (24), USH1F (MIM 602083) on chromosome 10 (150); 4 loci for USH2, USH2A at 1q41 (MIM 276901) (74, 82) , USH2B at 3p23-24.2 (MIM 276905) (56), USH2C at 5q14.3-21.3 (MIM 605472) (109) , and a fourth locus not yet defined (156); 2 loci for USH3, USH3A (MIM 276902) at chromosome 3q21-25 (122) and 1 locus on the long arm of chromosome 20 (M. Mustapha, D. Weil, S. Chardenoux, R. Slim, & C. Petit, unpublished data). Of these 12 genetic forms, which all are transmitted on the autosomal recessive mode, USH1B and USH2A are the most prevalent. The former accounts for 30% to 60% of the USH1 cases (2, 8, 15, 63) , the latter, for 74% to 82% of the USH2 cases (110, 156) .
THE USH GENES

USH1B
The gene responsible for Usher 1B (USH1B) was the first USH gene to be isolated. This cloning was greatly facilitated by the study of the shaker-1 (sh-1) mouse mutants (32, 118) . Indeed, the sh-1 phenotype had been assigned to the murine chromosomal region homologous to that defined for USH1B (22). Sh-1 mice exhibit head-tossing, circling behavior, and hyperactivity due to vestibular dysfunction. A rapidly progressive hearing loss accompanied by degeneration of the organ of Corti (70) is also exhibited. Although a lack of retinal degeneration had been reported in these mutants, the sh-1 phenotype was hypothesized to involve the USH1B orthologue. A positional cloning strategy led to the identification of the murine Myo7a gene, predicted to encode the unconventional myosin VIIA, in the sh-1 candidate interval. Because experimental evidence already supported a role of unconventional myosins in the auditory mechanotransduction process (43, 58) , the myosin VIIA gene was considered a promising candidate for both sh-1 and USH1B. Indeed, mutations in exons encoding the motor head of myosin VIIA were detected concurrently in sh-1 mice (42) and in USH1B patients (152) . MYO7A consists of 48 coding exons (17 for the head, 3 for the neck, and 28 for the tail of the molecule) and encodes several alternatively spliced forms, mainly differing in their motor head. It extends over 100 kb (27, 154) . Since the original report in 1995, a total of 81 different mutations have been detected in USH1B patients. They are distributed all along the gene, although somewhat clustered in the part encoding the motor head (2, 15, 29, 30, 37, 63, 81, 91, 152, 155, 157) . About half of the mutations are missense or in-frame insertions/deletions. There is no indication for a hot spot of mutations. Of the 10 sh-1 alleles, 7 have been analyzed; the mutations have roughly the same distribution and characteristics as the human mutations (42, 54, 96) . Interestingly, among the category of zebrafish circler mutants that are characterized by defective hair cells of the auditory-vestibular and lateral line systems (i.e., two likely homologous sensory systems) (102) , the five alleles of the mariner class carry myo7a mutations (36) .
Unconventional myosins form a large family that is presently divided into 16 classes (14a). These motor proteins move along the actin filaments by using the energy generated by the hydrolysis of ATP. Their highly conserved N-terminal motor head possesses the actin-and ATP-binding sites. It is followed by a neck region and a tail that is highly divergent from one myosin to another. The tail sequence determines the functional specificity of each myosin, as it contains various putative protein-protein interacting domains that bind to cargo molecules, regulatory factors, and components of the transduction pathways (14a). Unconventional myosins have been implicated in the formation and the movements of cytoplasmic expansions, in the movements of vesicles, the transport of mRNA, and in signal transduction (14a, 92, 97, 135) . The human myosin VIIA (Figure 3 ), 2215 amino acids in length (254 kDa), consists of a motor head domain of 729 amino acids, containing the ATP-and actin-binding motifs; a neck region of 126 amino acids, composed of five IQ (isoleucine-glutamine) motifs that are expected to bind calmodulin; and a long tail of 1360 amino acids (154) . The actin-based motility of the head was demonstrated recently (139) . The tail begins with a short coiled-coil domain (78 amino acids) that mediates the formation of homodimers (153) . The coiled-coil domain is followed by two large repeats of about 460 amino acids. Each repeat contains a MyTH4 (myosin tail homology 4) domain, of unknown function, and a domain homologous to the membrane-binding domain of the proteins of the FERM (4.1, ezrin, radixin, moesin) superfamily (28). The tandem association of Figure 3 Schematic representation of myosin VIIA. This unconventional myosin consists of a motor head that contains the ATP-and actin-binding sites, a neck region composed of five isoleucine-glutamine (IQ) motifs expected to bind calmodulin, and a long tail of 1360 amino acids. The tail begins with a short coiled-coil domain, which is implicated in the formation of homodimers. The coiled-coil domain is followed by two large repeats, each containing a MyTH4 (myosin tail homology 4) and a FERM (4.1, ezrin, radixin, moesin) domain. The two repeats are separated by a poorly conserved SH3 (src homology-3) domain.
the MyTH4 and FERM domains, which is also present in myosin V, myosin XV, and a plant kinesin (14a, 27, 115, 148), argues in favor of a functional significance for this pairing. These two repeats are separated by a poorly conserved SH3 (src homology 3) domain (27, 96), a type of domain known to interact with proline-rich regions (101) .
USH1C
In 1966, Kloepfer reported an unusually high frequency of USH patients in a small population of southwestern Louisiana who were descendents of French-speaking emigrants exiled from Acadia (Canada) in the eighteenth century (75) . In 1994, this form was individualized as USH1C by linkage analysis and, for a long time, has only been observed in patients related to this community (10, 69, 128) . The gene underlying USH1C was recently isolated using two different strategies, namely, a candidate gene approach (based on a subtracted cDNA library derived from microdissected sensory areas of the vestibular end organs) (143) and a positional cloning strategy (based on the analysis of a chromosomal deletion underlying a contiguous gene syndrome) (16). USH1C encodes a PDZ domain-containing protein, termed harmonin; it consists of 28 coding exons and spans about 51 kb (16, 143). So far, six mutations have been reported (16, 143, 163) , none of which is a missense mutation. Which mutation(s) cause the disease in the Acadian affected individuals is still not clear. Indeed, two distinct causative mutations have been reported, namely, an expanded intronic VNTR proposed to affect transcriptional and/or posttranscriptional processes (143) and an exonic substitution that is consistent with the creation of a new splice site and leads to a small in-frame deletion and an unstable transcript (16). One mutation, 238-239insC, was detected in several European individuals (143) who share a common haplotype, thus arguing in favor of a founder effect (163) . Mutation screening in a German population provided a minimal estimation of 12.5% of USH1C mutations among USH1 cases (163) .
USH1C encodes a variety of alternatively spliced transcripts that result from the differential use of eight exons. In the murine inner ear, these transcripts predict at least eight harmonin isoforms, ranging from 420 to 910 amino acids in length (143) . They can be distributed into three subclasses according to the number of domains they contain, namely, two or three PDZ domains, one or two coiled-coil domains, and the presence/absence of a PST (proline, serine, threonine) domain ( Figure 4 ). The coiled-coil domain(s) might be implicated in the dimerization of the protein. Proline-rich domains serve as binding sites for SH3, WW (trptrp), EVH1 [Drosophila enabled/VASP (vasodilator-stimulated phosphoprotein) homology 1] domains (129) , and the actin-regulatory protein profilin (65, 98) . PDZ domains are interacting domains, 80 to 90 amino acids in length, originally detected in PSD/SAP90 (postsynaptic density protein), Dlg-A (Drosophila tumor suppressor), and ZO-1 (tight junction protein). The PDZ domain-containing proteins form a vast class of molecules, with one representative in bacteria (111) . They are central organizers of high-order supramolecular complexes located at specific emplacements of the plasma membrane. They bind not only to transmembrane proteins, in particular, ionic channels or transporters (50, 71, 126), but also to actin or actin-binding proteins. Hence, they cluster and coordinate the activity of various plasma membrane proteins and bridge them to the cortical cytoskeleton (39, 41, 125) .
USH1D
The USH1D locus was defined by the study of a Pakistani family (149) . The gene was recently isolated independently by two groups. One discovery was the result of a collaborative study aimed at identifying the gene defect underlying the phenotype of the waltzer (v) deaf mouse mutants (17). Indeed, based on mapping data (23, 162), these mutants had been proposed as the mouse model for USH1D, even though no retinal anomaly has been observed in these mice (5) . The other group found the USH1D gene by a direct positional cloning strategy (19). This gene, CDH23 (MIM 605516), comprises 69 coding exons and spans more than 300 kb (17). It encodes a cadherin-related protein.
Eight distinct mutations have been reported, namely, two nonsense mutations, one single-codon deletion, one missense mutation, three splice-site mutations that are predicted to preserve the reading frame, and one truncating splice-site mutation (17, 19). In the three v mutants analyzed, a nonsense and two splice-site mutations were found (33) . USH1D seems to be the second most common genetic form of USH1 (8) . Interestingly, individuals homozygous for the CDH23 missense mutation present with a mild form of retinitis pigmentosa (almost undetectable in one patient) (17). A mild retinopathy was also observed in a family with a splice-site mutation preserving the reading frame (17). The predicted protein ( Figure 5 ), termed cadherin-23, is composed of 3354 amino acids (17). Its ectodomain is composed of 27 extracellular cadherin (EC) repeats (17), most of which possess the characteristic Ca 2+ -binding motifs of cadherins. These motifs are implicated in the calcium-dependent interaction between cadherins, which mediates cell-cell adhesion. The single transmembrane domain is followed by a 268 amino acid cytoplasmic region (17, 19). Cadherin-23 is more closely related to the subgroup of cadherins defined by the Drosophila fat, dachsous, and the human MEGF1 proteins, which are characterized by a large number of EC repeats (103, 161) . However, its intracytoplasmic part shows no homology with known proteins. In particular, no clear β-catenin-binding motif can be detected.
USH2A
The gene underlying USH2A has been isolated by a positional cloning strategy; it comprises 21 exons, with the first exon being entirely noncoding (38) . USH2A encodes a predicted 1551 amino acid (171 kDa) protein. This protein ( Figure 6 ) begins with a signal peptide and has a modular structure. It is composed of a N-terminal 285 amino acid unclassified domain, followed by a laminin domain VI module (about 200 residues) (156), a tandem array of 10 laminin-type EGF-like (LE) modules, and four fibronectin-like type III (F3) repeats. Of particular interest are the other types of proteins that contain domain VI motifs, namely, laminin chains α1, α2, α5, β1, β2, β3, γ 1, γ 3, and netrins. Laminins are the major noncollagenous components of basement membranes, and they are also present in some mesenchymal compartments. Netrins are small diffusable proteins involved in axon guidance. Therefore, the USH2A protein may be a novel extracellular matrix protein (38, 156) .
A total of 20 pathogenic mutations have been reported in USH2A patients, namely, 7 nonsense, 7 frameshift, 1 splice site, and 5 missense (of which 4 are in the laminin type VI domain) mutations (3, 38, 156) . Interestingly, the 2299delG (previously termed 2314delG) mutation appears particularly frequently, as it has been detected in 25% of a population of Spanish USH2 families (14) and in about Figure 6 Schematic representation of the USH2A encoded protein (usherin). The protein precursor has a signal peptide (SP), which is followed by a 285 amino acid unclassified domain, a laminin domain VI-like (L6) module, 10 laminin type EGF-like (LE) modules, and 4 fibronectin-like type III (F3) repeats. The C-terminal region (50 amino acids) has no detectable homology.
20% of USH2A families from Europe and the United States (156) . Finally, the discovery of 4 different missense mutations in the laminin type VI domain of the USH2A protein marks this region for a potentially critical role in the cochlea and retina.
TOWARD PATHOGENESIS
Some clues for understanding the pathogenesis of a genetically heterogeneous disease can be obtained from the pathohistological anomalies observed in animal models, the expression patterns of the underlying genes, the cellular and subcellular localization of the encoded proteins, and the elucidation of the network of molecular interactions in which these proteins are involved. Because so far the genes causative of Usher syndrome have mainly been cloned by groups working in the field of hereditary deafness, the knowledge acquired about the pathogenesis of the disease relates more to the cochlear than to the retinal dysfunction. Presently, more information is available for USH1B than for USH1C and USH1D. Preliminary results for USH2A are also presented.
Usher 1B
COCHLEAR PHENOTYPE: A PRIMARY SENSORY CELL DEFECT The hair bundle of inner ear sensory cells is a highly organized structure that displays a polarity axis in the plane of the epithelium. This planar polarity also manifests by the coordinated orientation of the hair bundles of the different hair cells. Within a bundle, the stereocilia are arranged in several rows of gradually increasing size, resembling a staircase ( Figure 7A ). The hair bundles have a U, V, or W shape. The kinocilium is located eccentrically at the vertex of the bundle; its position defines the vectorial orientation of the bundle. The hair bundle is also functionally polarized; its deflection in the direction of the kinocilium opens the mechanotransduction channels via the stretching of apical links, called the tip links (see Figure 2 ), which should gate these channels (59) . In the most severely affected sh-1 mouse mutants, the kinocilium is misplaced and the stereocilia display an irregular arrangement (124) (Figure 7B ). This disorganization of the hair bundle progressively increases after birth; stereocilia form small clumps and splay out (124) . Therefore, sh-1 mutants can be regarded as planar polarity mutants (34) . Into this category fall several Drosophila mutants affected in the polarity of hairs, sensory bristles, or ommatidia, which have permitted a genetic dissection of the underlying signaling pathway (99, 116) . Erratic positions of the stereocilia are also observed in mariner zebrafish mutants (36) . Moreover, although hair cells from sh-1 mice are able to transduce (117, 124) , whereas hair cells from mariner fishes seem unable to do so (102) , this apparent discrepancy may in fact reflect differences in the experimental conditions of this testing because mechanotransduction in sh-1 mutants requires much greater displacements of the hair bundle than in wild-type animals (76) . Therefore, it is reasonable to assume that the disorganization of the hair bundle plays a major role in the hearing loss of USH1B patients. Finally, the hair cells of both sh-1 mice and mariner zebrafish have lost the capacity to accumulate aminoglycosides. Whereas this has been initially interpreted as a defect in an apical endocytic pathway (117, 123) , recent results suggest that aminoglycosides may enter the sensory cells via the mechanotransduction channel (G. Richardson, personal communication).
Myosin VIIA is synthesized by numerous cell types; all are epithelial cells that, in most cases, possess microvilli and/or cilia (121) . Immunoelectron microscopy has shown that, in these cells, myosin VIIA is present all along the microvilli and the cilia (158) . In the mouse inner ear, myosin VIIA is first observed at embryonic day 10 (E10) in the otic vesicle (121) . Later, in the cochlea, the protein is restricted to the inner and outer hair cells in all the mammalian species tested (35, 53, 154) . It is present in the whole cell body and along the kinocilium (158) and stereocilia (35, 53, 154) . However, the strongest immunoreactivity is associated with the pericuticular necklace; this is a narrow apical region situated between the actin apical belt (associated with the adherens junctions) and the cuticular plate (a dense apical network of horizontal filaments in which the actin filament rootlets of the stereocilia are anchored) (see Figure 2 ). This region is characterized by the presence of a large pool of coated vesicles (64) . In the frog, an intense immunoreactivity has been detected at the base of the stereocilia (52), at the precise emplacements of the ankle links that, in this species, form the major subset of the lateral links that interconnect the stereocilia of the bundle [ (44, 133) ; also see Figure 2 ].
Recent insight into the function of myosin VIIA at the cellular level provided clues to the understanding of some of the phenotypic anomalies observed in the mouse and zebrafish mutants. Dictyostelium discoideum amoeba null mutants for a myosin that may be the orthologue of the mammalian myosin VIIA display impaired phagocytosis (134) and migration, which is related to a defective adhesion to particles and to substrate, respectively (138) . Moreover, two ligands of the Cterminal FERM domain of the mammalian myosin VIIA have been characterized. One is the type Iα regulatory subunit of the cAMP-dependent protein kinase (77) , which suggests that the activity of myosin VIIA and/or associated molecules could be modulated by cAMP-dependent phosphorylation. The other ligand, vezatin, is a novel ubiquitous transmembrane protein of the adherens junctions (78) . Vezatin interacts also with the cadherin-catenin junctional complex, which is involved in cell-cell adhesion and is linked to actin. At the junctions between hair cells and supporting cells (see Figure 2) , myosin VIIA, anchored by vezatin, is expected to create a tension force and thus to strengthen cell-cell adhesion (1) . The stabilization of these junctions could in turn stabilize the cuticular plate, hence the stereocilia, even though the cuticular plate seems to be attached to the adherens junctions only on the side of the shortest stereocilia (L. Tilney, personal communication). Interestingly, vezatin is also present at the base of the stereocilia, where it is tightly associated with the ankle links (78) (also see Figure 2 ). By its dynamic activity, the vezatin-myosin VIIA complex at the base of the stereocilia is expected to actively contribute to the cohesion of the hair bundle. Therefore, the loss of a functional vezatin-myosin VIIA complex at both the adherens junctions and the base of the stereocilia is likely to account for the splaying out of the stereocilia observed in myosin VIIA defective animals. Moreover, the presence of myosin VIIA all along the stereocilia in mammals suggests that myosin VIIA also interacts with the other lateral links of the stereocilia (see Figure 2) . A possible role at the level of the tip link should also be considered, the loss of which may contribute to the abnormal transduction observed in the myosin VIIA defective mouse and zebrafish mutants (76, 102) . Finally, as suggested by the abnormal position of the kinocilium in sh-1 mice, myosin VIIA at cell-cell junctions might also be implicated in the, as yet undescribed, reorganization and asymetric distribution of the microtubules and microfilaments that should accompany the movement of the kinocilium toward its final peripheral position during the establishment of the planar polarity (55, 136).
RETINAL PHENOTYPE In the mouse retina, myosin VIIA is first detected at E12 in the outer layer of the optic cup, which will give rise to the pigment epithelium cells. Thereafter, the protein is present in both the pigment epithelium cells and the photoreceptor cells in all species tested [although for unclear reasons, some antibodies failed to detect it in the rodent photoreceptors (35) ]. Myosin VIIA is localized in the apical processes of the pigment epithelium cells, some of which are involved in the phagocytosis of the outer disks that are exfoliated from the photoreceptors (35, 53, 158 ) (see Figure 1) . In the photoreceptors, the protein is present at the periphery of the connecting cilium, i.e., the slender stalk that joins the inner and outer segments (see Figure 1) . Finally, myosin VIIA has also been detected in the synaptic region of chick and macaque photoreceptor cells (35) .
No sign of retinal degeneration at any age has ever been observed in the sh-1 mouse mutants. Recently however, electroretinographic anomalies (a reduction of the amplitude of the wave response to light) have been reported in some sh-1 mouse mutants carrying a deleterious allele. The pigment epithelium cells have only been examined in a sh-1 mutant with a mildly deleterious allele. Phagosomes were found to be normal, but the melanosomes did not extend in the apical processes as they did in wild-type mice (85) (Figure 1 ). In the sh-1 mice, no morphological anomaly of the photoreceptors has been reported to date (in particular, no misposition of the connecting cilium evoking a polarity defect). However, a significant decrease of the opsin flow at the level of the connecting cilium has been observed (86, 160) . Myosin VIIA and actin, which are present along the connecting cilium (159), thus, may participate in the ciliary transport of opsins (86, 160) .
The visual loss in retinitis pigmentosa corresponds to the degeneration of photoreceptor cells. The molecular studies have revealed that, in most cases, the primary defects causing these cells to die are either photoreceptor cell or pigment epithelium cell defects (112) . Because both cell types express myosin VIIA, the cellular origin of the retinal disease in USH1B cannot be unambiguously established. The defect in melanosome transport in the pigment epithelium cells is not expected to be causative of the USH1B retinal degenerescence (85) . However, with respect to the outer disk phagocytosis function of the pigment epithelium cells, the abnormal phagocytosis that has been observed in amoeba null mutants for the putative orthologue of myosin VIIA is intriguing (134) .
Usher 1C
Ush1C is transcribed in all the murine tissues tested, with a higher expression in the eye, inner ear, kidney, and small intestine. Immunohistolabeling experiments have shown the presence of harmonin in all the hair cells of the inner ear (143); the protein is detected in the whole cell body and in the stereocilia. In the retina, harmonin is present in the photoreceptor layer (16). Therefore, the cochlear and retinal dysfunctions in USH1C may result from primary sensory cell defects. The various types of cells express different transcripts, with a greater variety in the inner ear than in the eye; moreover, some transcripts predicted to encode b isoforms (see Figure 4 ) have thus far only been detected in the inner ear. Very little information is available today on the pathogenesis of USH1C because no animal model exists. However, we consider the possibility of an interaction between myosin VIIA and harmonin as an attractive hypothesis, based on the following considerations: (a) These proteins, when defective, underlie the same phenotype; (b) they colocalize in the same cells, in particular in epithelial cells harboring microvilli; (c) PDZ domain-containing proteins are often associated with the sites of cell-cell contacts (80, 94, 99, 116) ; and (d) some PDZ domain-containing proteins interact with proteins of the FERM family (93, 114) . The diverse harmonin isoforms predict their involvement in distinct molecular complexes. Major functional information will certainly be obtained from the identification of the transmembrane proteins to which harmonins bind.
Usher 1D
Cdh23 is transcribed in a large variety of murine tissues (19, 33). The gene is highly expressed in the retina. In the inner ear, Cdh23 expression is restricted to the hair cells (33) . In the waltzer mutants, the kinocilium is mispositioned, the hair bundle becomes progressively disorganized, and the stereocilia clump together (33), i.e., a series of anomalies resembling those of myosin VIIA defective mutants. Hence, waltzer can also be classified as a planar polarity mutant. Interestingly, the Drosophila fat and dachsous cadherins, which belong to the same cadherin subclass as cadherin-23 (161), are involved in epithelial planar polarity (4) . Although the cellular distribution of cadherin-23 remains unknown, the usual localization of cadherins at membrane-membrane interacting sites in conjunction with the waltzer phenotype argue in favor of a role of cadherin-23 at the junctions with the supporting cells and/or at the level of lateral links. Interestingly, the cadherins present at the junctions between hair cells and supporting cells in the adult mouse have not been characterized yet (79) . Moreover, it is noteworthy that in the presence of a calcium chelator, some of the lateral links are proteolyzed (44) and the tip link is disrupted (95) . Because cadherins also undergo proteolysis in the absence of calcium (61, 106) , cadherins might be components of these links. Because the myosin VIIA ligand vezatin interacts with the cadherin-catenin complex, an exciting possibility is that myosin VIIA and cadherin-23 belong to the same macromolecular complex required to transmit adhesion forces to the cytoskeleton. Arguing in favor of this interaction, double heterozygote v/+ sh-1/+ mice become deaf at 3 to 6 months of age, whereas v/+ and sh-1/+ single heterozygote animals have normal hearing (32) .
As discussed above, in the absence of a retinal degeneration in USH1B and USH1D mouse models and because of the lack of information on the cellular and/or subcellular localization of vezatin, harmonin, and cadherin-23 in the retina, the pathogenesis of the USH1 retinitis pigmentosa remains highly speculative. However, the absence of retinitis pigmentosa in both the sh-1 and the waltzer deaf mouse mutants argues in favor of the involvement of the USH1 gene products in a common process in the retina too. Similar to the adhesion defect in the auditory hair cells proposed in USH1, the myosin VIIA signaling pathway may act at some of the membrane-membrane adhesion sites of the photoreceptor cells. These include the synaptic junctions, the junctions with the Müller glial cells, and the contact sites of the calycal process (emerging from the inner segment) (44) with the connecting cilium and the basal part of the outer segment (see Figure 1) . A possible role at this latter emplacement should be considered, especially because (a) mouse photoreceptor cells lack calycal processes, thus potentially explaining the retinal phenotype discrepancy between humans and mouse, and (b) the fibrous links that connect the calycal process to the connecting cilium and outer segment share some molecular components with the lateral links of the hair cells (44).
Usher 2A
No animal model of USH2A is yet available. In situ hybridization studies did not detect the USH2A transcript in either the photoreceptor cells or the auditory sensory cells; but rather, it was found in pigment epithelial cells and a variety of epithelial cells of the cochlea, including endothelial cells of the stria vascularis. Immunohistolabeling experiments have revealed usherin as a component of basement membranes in the retina and cochlea (15a). These preliminary data indicate that the cochlear and retinal sensory cells are unlikely to be the primary targets of the USH2A genetic defect.
USH GENES AND ISOLATED DEAFNESS OR RETINITIS PIGMENTOSA
In 1994, the second reported locus responsible for an autosomal recessive form of isolated deafness, DFNB2 (MIM 600060), was mapped to a 6 cM interval overlapping the candidate region for USH1B, through the study of a large consanguineous family living in the central part of Tunisia (49) . Thereafter, several other USH loci and DFNB loci were assigned to overlapping genomic regions (see Table 1 ), namely, USH1C (69) and DFNB18 (MIM 602902) (62), USH1D (149) and DFNB12 (MIM 601386) (25), USH1F (150) and DFNB23 (http://www.uia.ac.be/dnalab/hhh/), USH2B (56) and DFNB6 (MIM 600971) (40), USH3 (122) and DFNB15 (MIM 601869) (26). Moreover, a dominant form of isolated deafness, DFNA11, was also mapped to the same chromosomal region as USH1B and DFNB2. Although this suggested that USH genes could also be causative genes for isolated deafness, the candidate intervals initially defined for most of the loci were very large (i.e., exceeded 10 cM). However, it is now established that MYO7A, which underlies USH1B, also underlies the isolated forms of deafness DFNB2 (87, 153) and DFNA11 (88) . Moreover, strong indication supporting the involvement of CDH23 and USH1C in DFNB12 (19) and DFNB18 (X-Z. Liu, personal communication), respectively, exists. In addition, USH2A underlies isolated retinitis pigmentosa (119) . Finally, the idea of a continuum between the syndromic and nonsyndromic situations tends to emerge from several recent studies reporting variations of the phenotype within a given family (13, 89, 90, 119) .
USH1B and Isolated Deafness
In addition to the aforementioned Tunisian family (49) , two small DFNB2 families from China have been identified (87) . In the three DFNB2 families, some patients complained of balance problems and/or had abnormal vestibular tests. The hearing loss was severe to profound and congenital in the Chinese families, whereas it was progressive in the Tunisian family (the age of onset ranged from birth to 16 years). Notably, in the Tunisian family, one adult homozygous for the causative mutation had normal hearing. Moreover, a few of the 25 members of this family who carry the biallelic mutation subsequently developed signs of retinal degeneration, whereas others of the same age did not (13). In the Tunisian family, a G>A substitution in the last nucleotide of exon 16 of MYO7A was detected (153) . This mutation is predicted both to substitute isoleucine for methionine 599 in the motor head of myosin VIIA and to affect the splicing of the mutated exon, resulting in the skipping of this exon in a large proportion of the mature transcripts (151) . The expected product of the abnormally spliced transcript is a defective myosin VIIA chain with a 46 amino acid in-frame deletion in the motor head, which might dimerize with the normal chain and thus exert an intra/inter allelic dominant negative effect. One Chinese family was homozygous for the amino acid substitution Arg244Pro located in the motor head of myosin VIIA (87) . Affected members of the second Chinese family were compound heterozygotes, who carried a 1 bp insertion in exon 28, leading to the truncation of the tail, on one allele and an acceptor splice site mutation of intron 3 on the other allele (87) . Whether the type of the mutation accounts for the expression of either a USH or a DFNB phenotype is difficult to determine. Indeed, on the one hand, in none of the three DFNB2 families do the detected mutations unequivocally predict the complete absence of the protein in the patients. On the other hand, the large phenotypic heterogeneity observed in the Tunisian family, ranging from the lack of any sensory defect to complete Usher syndrome (13), strongly argues in favor of the role of genetic and/or environmental modulating factors. It is noteworthy that the dual sensory dysfunction that was observed in some of the Tunisian patients resembles that of USH3. Along the same line, in one family affected by an atypical Usher syndrome with a progressive hearing loss (i.e., most closely related to USH3), mutations in MYO7A have been detected. These patients were compound heterozygotes who carried two missense mutations, namely, a Leu651Pro substitution in the motor head and an Arg1602Gln substitution at the C-terminal end of the first FERM domain (90) . As the latter mutation has also been observed in an authentic USH1 family (155) , the milder phenotype in this USH3-like family has been proposed to be the result of a genetic background effect (even though the precise impact of the motor head Leu651Pro mutation was unknown) (90) .
In the single DFNA11 family reported to date, patients presented with a moderate bilateral hearing loss on all sound frequencies, which appeared in the first decade and then progressed. Vestibular anomalies were detected in some of the individuals. In this family, a 9 bp in-frame deletion located in exon 23, which encodes the coiled-coil domain, was detected (88) . The mutated protein may form an inactive dimer with the wild-type myosin VIIA chain (153) and thus have a dominant negative effect. The persistence of some functional wild-type dimers would account for the moderate hearing loss and the absence of retinitis pigmentosa.
In summary, mutations in MYO7A can result not only in USH1 but also in USH3-like phenotypes, as well as in dominant or recessive isolated deafness with any degree of severity, congenital or progressive, with or without vestibular dysfunction. So far, no MYO7A mutation that leads to isolated retinitis pigmentosa has been discovered, meaning that, for unknown reasons (e.g., a myosin activity with a different critical threshold concentration, a different protein turnover, a cell restricted redundancy, etc.), mutations in myosin VIIA have a more deleterious effect in the inner ear than in the retina. At present, in some cases, the involvement of the genetic background and/or environmental factors in the clinical features can be inferred from distinct phenotypes either present within the same family or associated with the same mutation in different families. In contrast, in the absence of a functional testing of the activity of the various mutated forms of myosin VIIA, the individual effect of a given mutation on the phenotype remains speculative.
USH1D and Isolated Deafness
Whereas only deletions and nonsense or frameshift mutations in CDH23 have been found in authentic USH1D patients (see above), missense mutations have been detected in several families affected by the isolated form of deafness DFNB12, which is characterized by severe to profound hearing loss (19). Although the entire gene has not yet been explored in these patients, we assume that these mutations are pathogenic. Accordingly, we suggest that the mutation type may play a crucial role in the phenotypic expression of CDH23 defects. In addition, it is worth noting that the gene encoding protocadherin-15, which is defective in the deaf mouse mutant Ames waltzer (5) [which also displays a disorganization of the hair bundle (6)], has been proposed to underlie USH1F and the isolated deafness DFNB23 (5) (see Note Added in Proof, p. 297).
USH2A and Isolated Retinitis Pigmentosa
The USH2A 2299delG mutation is present at the homozygous state not only in typical USH2 patients, but also in USH3-like patients who present late onset progressive deafness that is occasionally associated with vestibular dysfunction (89) .
The genetic background is not the only source of these differences because they were also observed in monozygotic twins (89) . In addition, this mutation has also been detected at the heterozygous state in 4% of patients affected by a recessive form of isolated retinitis pigmentosa who only in the second instance reported mild subjective hearing impairment (119) . Finally, a Cys759Phe missense mutation in the fifth LE motif of usherin has been observed in about 4.5% of the cases of recessive retinitis pigmentosa without an auditory defect in North America (119) . These patients were either homozygotes for the mutation or compound heterozygotes for one of the aforementioned microdeletions detected in USH2 patients (38) . Therefore, mutations in USH2A may account for a substantial proportion (i.e., more than 4.5%) of isolated retinitis pigmentosa (119) .
CONCLUDING REMARKS
From the recent progress made in characterizing the molecular bases of Usher syndrome, some new ideas are currently emerging about the pathogenesis of this clinically and genetically heterogeneous disorder. Three of them deserve particular mention:
s The results obtained so far on both USH1 B, C, D genetic forms and USH2A
indicate that distinct pathogenic processes are likely to account for the different clinical subtypes of the syndrome. In contrast, the various genetic forms of USH1 could result from molecular defects of the same signaling pathway. s The misposition of the kinocilium during the development of the hair bundle of the auditory sensory cell, which is observed in the mouse models of USH1B and USH1D as well as the anomaly of the connecting cilium of the photoreceptor cell, which has been reported in some USH patients, suggest the existence of a planar polarity defect in USH1. Hence, clarifying USH1 pathogenesis might contribute to the elucidation of the mechanisms involved in the generation of planar polarity in mammals. s At least three USH genes also underlie isolated auditory or visual sensory defects. Moreover, the idea of phenotypic continuums between the syndromic and nonsyndromic situations tends to emerge from several recent reports and to substitute for the classical nosologic frontiers. The analysis of additional mutations in USH genes, combined with the study of mutated gene products and careful clinical descriptions, should permit a more accurate estimation of possible direct phenotype-genotype correlation. Perhaps more importantly, these studies should also provide the basis for wide-scale segregation analyses aimed at identifying "modifier genes" in the rest of the genome. From this knowledge, we should gain additional insight into the pathogenic processes involved in Usher syndrome and thereby be guided in the search for targeted therapies. 
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